BG
INSY

BlackRock Group’s Insys Therapeutics, Inc. INSY Stock Holding History

BlackRock Group’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.02M Sell
110,517
-21,638
-16% -$244K ﹤0.01% 2125
2016
Q3 		$1.56M Buy
132,155
+39,140
+42% +$595K ﹤0.01% 1783
2016
Q2 		$1.2M Buy
93,015
+1,976
+2% +$28.8K ﹤0.01% 1874
2016
Q1 		$1.46M Sell
91,039
-28,386
-24% -$539K ﹤0.01% 1721
2015
Q4 		$3.42M Buy
119,425
+108,244
+968% +$3M ﹤0.01% 1227
2015
Q3 		$318K Buy
11,181
+1,365
+14% +$50.2K ﹤0.01% 2380
2015
Q2 		$353K Buy
9,816
+3,340
+52% +$104K ﹤0.01% 2389
2015
Q1 		$189K Buy
6,476
+2,308
+55% +$61K ﹤0.01% 2514
2014
Q4 		$88K Buy
4,168
+140
+3% +$2.77K ﹤0.01% 2687
2014
Q3 		$78K Sell
4,028
-405,240
-99% -$6.36M ﹤0.01% 2623
2014
Q2 		$6.39M Buy
409,268
+227,220
+125% +$3.67M ﹤0.01% 1064
2014
Q1 		$3.77M Sell
182,048
-257,101
-59% -$5.1M ﹤0.01% 1228
2013
Q4 		$5.67M Buy
439,149
+50,652
+13% +$703K ﹤0.01% 1044
2013
Q3 		$4.53M Sell
388,497
-36,303
-9% -$298K ﹤0.01% 1104
2013
Q2 		$1.96M Buy
+424,800
New +$1.56M ﹤0.01% 1294

Other funds holding INSY

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Group's INSY Position: Q4 2016 in Review

BlackRock Group reduced its Insys Therapeutics, Inc. (INSY) stake by 16% in Q4 2016, selling an estimated $244K and leaving 110,517 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #2125.

BlackRock Group first reported a position in INSY in Q2 2013 and has held it in 15 quarters since. The position peaked at $6.39M in Q2 2014. 138 funds tracked by Wall St. Rank hold INSY as of Q4 2016.

  • BlackRock Group held 110,517 shares of Insys Therapeutics, Inc. worth $1.02M as of Q4 2016.
  • BlackRock Group sold 21,638 Insys Therapeutics, Inc. shares in Q4 2016, an estimated $244K.
  • Insys Therapeutics, Inc. made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2125 holding.
  • BlackRock Group first reported a position in Insys Therapeutics, Inc. in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Group's Insys Therapeutics, Inc. position peaked at $6.39M in Q2 2014.
  • 138 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.